Megan Gagliardi is thankful to have a physical reminder of her heart transplant to reflect on each day. “I love my scar, and I love showing people what I’ve been through. It’s a huge part of me.”
UAB researchers found that, from 2012-2014, Medicare was the primary payer for more than 90 percent of TAVR procedures.
Researchers will train community health workers to promote tobacco cessation among young African-American men in rural Alabama with the support of UAB experts through telehealth.
The infiltration of macrophages into the heart is a required step on the path to heart failure in a preclinical model.
The Alabama Vaccine Research Clinic will be testing the efficacy of a vaccine that could help combat a rare strain of avian influenza.
The Health Disparities Research Symposium highlights the work of undergraduate, graduate, faculty and community investigators.
This microRNA is a biomarker for bronchopulmonary dysplasia, a disease that can lead to death or long-term disease in extremely low birth-weight infants.
UAB research shows that splenic leukocytes resolve inflammation in heart failure.
Much like other muscles, when the heart works during the normal daytime hours, it needs a period of rest to repair itself.
Research shows protection against the linked heart damage and kidney dysfunction known as cardiorenal syndrome.
Members of an Air Force Special Operations Surgical Team based at UAB are awarded Bronze Stars for their actions while deployed overseas.
Some 70 percent of patients needing a marrow transplant do not have a fully matched donor in their family.

A national task force suggests hormone therapy does not help with chronic conditions.

At UAB, Alexa Wade found inspiration, open lab doors and an adept mentor.
S. Louis Bridges Jr., M.D., Ph.D., will serve as vice president of the Rheumatology Research Foundation.
A UAB researcher investigates how lupus develops and why certain demographics are at higher risk of flare-ups.
UAB provides emotional, social and spiritual care beyond the pain of life-threatening illnesses and diseases to help patients have the best quality of life.
ECMO and autoantibody reduction through plasma exchange, experimental therapies not available everywhere, help end an Alabama woman’s five-month medical ordeal.
Inhibition of this microRNA might improve response to newer diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta.
CHAAMPS exists to develop, implement and evaluate interventions to improve African-American men’s health through research, outreach and training.
Page 1 of 10
Back to Top